Bausch Health Companies | VRX - Ordinary Share Capital



Bausch Health Companies reported $369.75M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Amgen USD 538M 33.04B Jun/2025
ANI Pharmaceuticals USD 2K 0 Mar/2025
Aurora Cannabis CAD 56.25M 6.92B Jun/2025
Bausch Health Companies USD 369.75M 10.14B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Canopy Growth CAD 205.15M 8.47B Jun/2025
Corcept Therapeutics USD 105.29M 105.15M Jun/2025
Danaher USD 715.9M 706.9M Jun/2025
Drreddys Laboratories INR 832.37M 1.63M Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
Novo Nordisk 4.44B 3.99B Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Prestige Brands USD 49.21M 48.65M Jun/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025